Elo Mutual Pension Insurance Co Raises Holdings in The Clorox Company (NYSE:CLX)

Elo Mutual Pension Insurance Co increased its holdings in The Clorox Company (NYSE:CLX) by 13.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 11,609 shares of the company’s stock after acquiring an additional 1,375 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Clorox were worth $1,584,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Norges Bank purchased a new stake in Clorox in the 4th quarter valued at about $128,382,000. D.A. Davidson & CO. raised its stake in shares of Clorox by 6.3% in the 4th quarter. D.A. Davidson & CO. now owns 16,228 shares of the company’s stock valued at $2,314,000 after acquiring an additional 968 shares during the period. Corient Private Wealth LLC lifted its holdings in shares of Clorox by 7.1% in the 4th quarter. Corient Private Wealth LLC now owns 33,570 shares of the company’s stock worth $4,787,000 after acquiring an additional 2,230 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in Clorox by 1.0% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 48,102 shares of the company’s stock valued at $6,859,000 after purchasing an additional 498 shares during the last quarter. Finally, US Bancorp DE raised its position in Clorox by 0.5% in the fourth quarter. US Bancorp DE now owns 131,972 shares of the company’s stock valued at $18,818,000 after purchasing an additional 707 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $163.33 on Friday. The stock has a market cap of $20.28 billion, a price-to-earnings ratio of 84.63, a PEG ratio of 3.29 and a beta of 0.40. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The business has a 50 day moving average price of $149.14 and a 200 day moving average price of $143.78.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Equities research analysts anticipate that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.51% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CLX. Barclays lifted their price objective on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. Citigroup boosted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. DA Davidson restated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a report on Friday, August 2nd. Finally, Argus raised Clorox to a “hold” rating in a research report on Tuesday, June 4th. Six equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $143.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.